Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Y-chromosome Microdeletions From Infertile Men on the Chromosomal Constitution of Their Spermatozoa and Embryos. Combined IntraCytoplasmatic Sperm Injection (ICSI) and Preimplantation Genetic Screening (PGS) as Treatment Strategy.

NCT02527954 is registered in ClinicalTrials.gov with Instituto Valenciano de Infertilidad, IVI Alicante as lead sponsor.

NCT NCT02527954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Y-chromosome Microdeletions From Infertile Men on the Chromosomal Constitution of Their Spermatozoa and Embryos. Combined IntraCytoplasmatic Sperm Injection (ICSI) and Preimplantation Genetic Screening (PGS) as Treatment Strategy.
Lead sponsor
Instituto Valenciano de Infertilidad, IVI Alicante
Phase
Observational
Overall status
Terminated
Start date
September 22, 2015
Completion date
June 11, 2018
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

male sterility due to y-chromosome deletions